Hitomi Y, Sugiyama K, Esumi H
Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1, Kashiwanoha, Chiba, Kashiwa, 277, Japan.
Biochem Biophys Res Commun. 1998 Oct 9;251(1):11-6. doi: 10.1006/bbrc.1998.9406.
Nagase analbuminemic rats (NAR) are deficient in serum albumin due to skipping of the albumin exon H caused by a mutation in the intron HI. This mutation deletes nucleotides from +5 to +11 in the 5' splice site region, where it interacts with U1snRNA. To determine whether the mutation can be suppressed by the compensatory base substitution in U1snRNA, we constructed mutated U1snRNA genes with various degrees of complementarity to the mutated 5' splice site. Several mutated U1snRNA genes activated the mutated 5' splice site of the intron HI, when cotransfected with the albumin minigene derived from NAR. In vivo activity of these mutated U1snRNAs correlated well with the predicted thermodynamic stability. Since mutation in the 5' splice site is one of common causes of genetic defects in human (5), these data indicate that NAR is a good model system to examine the possibility of gene therapy using a mutated U1snRNA.
长谷川无白蛋白血症大鼠(NAR)由于内含子HI中的突变导致白蛋白外显子H跳跃,血清白蛋白缺乏。该突变在5'剪接位点区域删除了从+5到+11的核苷酸,在此区域它与U1snRNA相互作用。为了确定该突变是否能被U1snRNA中的补偿性碱基替换所抑制,我们构建了与突变的5'剪接位点具有不同互补程度的突变U1snRNA基因。当与源自NAR的白蛋白小基因共转染时,几个突变的U1snRNA基因激活了内含子HI的突变5'剪接位点。这些突变U1snRNA的体内活性与预测的热力学稳定性密切相关。由于5'剪接位点的突变是人类遗传缺陷的常见原因之一,这些数据表明NAR是一个很好的模型系统,可用于研究使用突变U1snRNA进行基因治疗的可能性。